DrugPatentWatch Database Preview

Pharmalucence Company Profile

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PHARMALUCENCE, and what generic and branded alternatives to PHARMALUCENCE drugs are available?

PHARMALUCENCE has fifteen approved drugs.

Summary for Pharmalucence

US Patents:	0
Tradenames:	15
Ingredients:	14
NDAs:	15

Drugs and US Patents for Pharmalucence

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmalucence	TECHNETIUM TC99M MERTIATIDE KIT	technetium tc-99m mertiatide kit	INJECTABLE;INJECTION	208994-001	Jul 12, 2019	AP	RX	No	No
Pharmalucence	IODOHIPPURATE SODIUM I 131	iodohippurate sodium i-131	INJECTABLE;INJECTION	017313-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmalucence	SODIUM PERTECHNETATE TC 99M	technetium tc-99m sodium pertechnetate	SOLUTION;INJECTION, ORAL	017321-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmalucence	CIS-MDP	technetium tc-99m medronate kit	INJECTABLE;INJECTION	018124-001	Approved Prior to Jan 1, 1982		RX	No	No
Pharmalucence	SELENOMETHIONINE SE 75	selenomethionine se-75	INJECTABLE;INJECTION	017322-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for Pharmalucence

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pharmalucence	IOBENGUANE SULFATE I 131	iobenguane sulfate i-131	INJECTABLE;INJECTION	020084-001	Mar 25, 1994	4,584,187

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Pharm Assoc
• Pharm Res Assoc
• Pharm Sourcing
• Pharm Spec
• Pharm Ventures